GVI

Green Valley Investors Portfolio holdings

AUM $1.76B
1-Year Return 5.68%
This Quarter Return
+1.98%
1 Year Return
+5.68%
3 Year Return
+59.49%
5 Year Return
+81.18%
10 Year Return
AUM
$5.2B
AUM Growth
+$216M
Cap. Flow
+$127M
Cap. Flow %
2.44%
Top 10 Hldgs %
63.3%
Holding
27
New
2
Increased
Reduced
3
Closed

Sector Composition

1 Healthcare 56.96%
2 Materials 12.56%
3 Consumer Discretionary 12.13%
4 Communication Services 9.91%
5 Consumer Staples 8.44%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ESRX
1
DELISTED
Express Scripts Holding Company
ESRX
$805M 15.49%
9,050,000
CELG
2
DELISTED
Celgene Corp
CELG
$532M 10.25%
4,600,000
JNJ icon
3
Johnson & Johnson
JNJ
$425B
$353M 6.8%
3,625,000
GILD icon
4
Gilead Sciences
GILD
$138B
$351M 6.76%
3,000,000
LKQ icon
5
LKQ Corp
LKQ
$8.11B
$236M 4.54%
7,800,000
WMT icon
6
Walmart
WMT
$825B
$213M 4.1%
9,000,000
SYK icon
7
Stryker
SYK
$144B
$210M 4.05%
2,200,000
TJX icon
8
TJX Companies
TJX
$155B
$199M 3.82%
6,000,000
MAR icon
9
Marriott International Class A Common Stock
MAR
$72.7B
$196M 3.77%
2,634,371
DIS icon
10
Walt Disney
DIS
$207B
$194M 3.73%
1,700,000
BHC icon
11
Bausch Health
BHC
$2.51B
$178M 3.42%
800,000
CMCSA icon
12
Comcast
CMCSA
$119B
$174M 3.36%
5,800,000
POT
13
DELISTED
Potash Corp Of Saskatchewan
POT
$163M 3.13%
5,250,000
TMO icon
14
Thermo Fisher Scientific
TMO
$179B
$156M 3%
1,200,000
IFF icon
15
International Flavors & Fragrances
IFF
$16.5B
$153M 2.94%
1,400,000
-100,000
-7% -$10.9M
ABT icon
16
Abbott
ABT
$229B
$147M 2.83%
3,000,000
TFCFA
17
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$146M 2.82%
+4,500,000
New +$146M
PX
18
DELISTED
Praxair Inc
PX
$120M 2.3%
+1,000,000
New +$120M
PG icon
19
Procter & Gamble
PG
$370B
$108M 2.08%
1,380,000
HSIC icon
20
Henry Schein
HSIC
$8.34B
$98.1M 1.89%
1,760,367
-279,633
-14% -$15.6M
APD icon
21
Air Products & Chemicals
APD
$63.4B
$82.1M 1.58%
648,600
DD icon
22
DuPont de Nemours
DD
$32.3B
$81.9M 1.58%
793,067
SYY icon
23
Sysco
SYY
$38.2B
$72.2M 1.39%
2,000,000
ABBV icon
24
AbbVie
ABBV
$382B
$67.2M 1.29%
1,000,000
-1,680,000
-63% -$113M
VRTX icon
25
Vertex Pharmaceuticals
VRTX
$101B
$61.7M 1.19%
500,000